Yi-Ching Wang
Overview
Explore the profile of Yi-Ching Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
3294
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chen T, Wang Y, Wu T, Chen C, Cheng C, Hsueh I, et al.
Am J Occup Ther
. 2024 Jun;
78(4).
PMID: 38885526
Importance: Effective communication skills (CS) are essential for occupational therapists. The Gap-Kalamazoo Communication Skills Assessment Form (GKCSAF) is a standard tool for assessing the CS of medical residents. However, the...
12.
Su P, Chen C, Yu M, Kuo I, Yang P, Hsu C, et al.
Biomed Pharmacother
. 2024 May;
176:116825.
PMID: 38820971
Considering the limited efficacy of current therapies in lung, colorectal, and pancreatic cancers, innovative combination treatments with diverse mechanisms of action are needed to improve patients' outcomes. Chitinase-3 like-1 protein...
13.
Yang Y, Hu M, Zeng Y, Tseng Y, Chen Y, Su W, et al.
Cell Death Dis
. 2024 May;
15(5):356.
PMID: 38778059
IL-33 is a danger signal that binds to its receptor ST2L to promote tumor progression. This study identifies the IL-33/ST2L positive-feedback loop and the trafficking of ST2L membrane presentation in...
14.
Young M, Wang S, Chen Y, Liu C, Hsu K, Tang S, et al.
Cell Death Differ
. 2024 Mar;
31(5):574-591.
PMID: 38491202
Drug resistance in cancer therapy is the major reason for poor prognosis. Addressing this clinically unmet issue is important and urgent. In this study, we found that targeting USP24 by...
15.
Kuo W, Kuo I, Hsieh H, Wu S, Su W, Wang Y
J Biomed Sci
. 2024 Feb;
31(1):20.
PMID: 38321486
Background: Programmed cell death protein 1 (PD-1) is an immune checkpoint receptor expressed on the surface of T cells. High expression of PD-1 leads to T-cell dysfunction in the tumor...
16.
Lien H, Wang Y, Chen Y, Fan S, Chen M, Chiang H, et al.
Hong Kong J Occup Ther
. 2023 Nov;
36(2):110-117.
PMID: 38027052
Purpose: To examine the consistency between patient- and occupational therapist-reported judgments of patients' ability and change in ADL abilities. Materials: Patient- and therapist-reported ADL abilities were assessed using a Visual...
17.
Singh S, Yeat N, Wang Y, Lin S, Kuo I, Wu K, et al.
Cell Death Dis
. 2023 Oct;
14(10):671.
PMID: 37821451
Aberrant overexpression or activation of EGFR drives the development of non-small cell lung cancer (NSCLC) and acquired resistance to EGFR tyrosine kinase inhibitors (TKIs) by secondary EGFR mutations or c-MET...
18.
Liu H, Shih Y, Wang W, Chang W, Wang Y
FASEB J
. 2023 Sep;
37(10):e23181.
PMID: 37668436
NEDDylation is a type of protein post-translational modification that has high similarity to ubiquitination. UBE1C encodes NEDDylation E1 enzyme, locates at chromatin region 3p14.1 and shows high gene dosage amplification...
19.
Huang S, Hsieh H, Shieh J, Su W, Wang Y
Biofactors
. 2023 Aug;
50(1):214-227.
PMID: 37647209
Zinc finger protein ZNF322A is an oncogenic transcription factor. Overexpression of ZNF322A activates pro-metastasis, cancer stemness, and neo-angiogenesis-related genes to enhance lung cancer progression. However, the upstream regulator of ZNF322A...
20.
Wu S, Wang Y, Zuchini R, Lan K, Liu H, Lan S
Autophagy
. 2023 May;
20(4):933-934.
PMID: 37151129
RAB37 GTPase regulates cargo exocytosis by cycling between an inactive GDP-bound form and an active GTP-bound form. We reveal that RAB37 simultaneously regulates autophagy activation and tissue inhibitor of metalloproteinase...